C-Reactive Protein (CRP) in Obese Diabetic Women

Clinical trial NCT00262548 · COMPLETED

Trial details

NCT number: NCT00262548
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2005-10-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.